Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice-Reference-Cited by-同舟云学术

Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

Published:2003-11-02 Issue:12 Volume:9 Page:1477-1483
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Okazaki Taku,Tanaka Yoshimasa,Nishio Ryosuke,Mitsuiye Tamotsu,Mizoguchi Akira,Wang Jian,Ishida Masayoshi,Hiai Hiroshi,Matsumori Akira,Minato Nagahiro,Honjo Tasuku

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm955.pdf

Reference38 articles.

1. Richardson, P. et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93, 841–842 (1996).

2. Cohn, J.N. et al. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on heart failure research. Circulation 95, 766–770 (1997).

3. Matsumori, A. et al. Epidemiologic and clinical characteristics of cardiomyopathies in Japan. Circ. J. 66, 323–236 (2002).

4. Herskowitz, A., Neumann, D.A. & Ansari, A.A. Concepts of autoimmunity applied to idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 22, 1385–1388 (1993).

5. Pankuweit, S. et al. Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J. Mol. Cell. Cardiol. 29, 77–84 (1997).

Cited by 594 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of myocardial toxicity of antitumor drugs and potential therapeutic strategies: A review of the literature;Current Problems in Cardiology;2024-11

2. PD-L1 and PD-1 in immune regulation and their implications in blood cancers;Advances in Cancer Biology - Metastasis;2024-10

3. Steroid-Refractory Myocarditis Induced by Immune Checkpoint Inhibitor Responded to Infliximab: Report of Two Cases and Literature Review;Cardiovascular Toxicology;2024-09-10

4. An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injury;Nature Cardiovascular Research;2024-08-15

5. Gasdermin-E-mediated pyroptosis drives immune checkpoint inhibitor-associated myocarditis via cGAS-STING activation;Nature Communications;2024-08-05